TABLE 1.
N = 37 | |
---|---|
Age (years), mean ± SD (range) | 65 ± 8.7 (42 to 85) |
Sex, M:F | 32:5 |
Tumor histology, n (%) | |
Adenocarcinoma | 29 (78%) |
Squamous Cell Carcinoma | 5 (14%) |
High Grade Dysplasia in Barrett Esophagus | 3 (8%) |
Tumor Location, n (%) | |
Distal Esophagus, GE Junction | 34 (92%) |
Mid Thoracic Esophagus | 3 (8%) |
Neo-adjuvant treatment, n (%) | |
Radiation only | 3 (8%) |
Chemotherapy only | 2 (5%) |
Chemotherapy and Radiation | 15 (41%) |
Pathological Stage AJCC Classification | |
High Grade Dysplasia in Barrett Esophagus | 3 (8.1%) |
0 | 4 (10.8%) |
I | 3 (8.1%) |
II | 14 (37.8%) |
III | 12 (32.4%) |
IV | 1 (2.7%) |